Pliant Therapeutics Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Pliant Therapeutics stock has a consensus rating of "Hold" and an average price target of $2.67. The average 1-year stock price forecast is 130.17% higher than the current stock price, while the lowest is $2.00 (+72.41%) and the highest is $3.00 (+158.62%).

Price Target: $2.67 (+130.17%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$2.00	$2.67	$3.00	$3.00
Change	+72.41%	+130.17%	+158.62%	+158.62%

* Price targets were last updated on May 12, 2026.

Analyst Ratings

The average analyst rating for Pliant Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Feb '26	Mar '26	May '26
Strong Buy	1	1	0	0	0	0
Buy	1	1	1	1	1	1
Hold	7	6	6	5	4	4
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	10	9	8	7	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst Oppenheimer No rating	Oppenheimer	Hold Maintains n/a	Hold	Maintains	n/a	n/a	May 13, 2026
Edward Nash Canaccord Genuity	Canaccord Genuity	Hold Maintains $3	Hold	Maintains	$3	+158.62%	May 12, 2026
Yasmeen Rahimi Piper Sandler	Piper Sandler	Buy Maintains $3	Buy	Maintains	$3	+158.62%	May 12, 2026
Brian Abrahams RBC Capital	RBC Capital	Hold Maintains $2	Hold	Maintains	$2	+72.41%	May 12, 2026
Joseph Stringer Needham	Needham	Hold Maintains n/a	Hold	Maintains	n/a	n/a	May 12, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

3.00M

EPS This Year

-1.42

from -2.40

EPS Next Year

-0.95

from -1.42

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	7.57M	9.69M	1.58M	-	-	-
Operating Income	-97.54M	-127.20M	-184.15M	-228.37M	-150.07M	-93.55M
Net Income	-97.26M	-123.32M	-161.34M	-210.30M	-149.34M	-87.43M
EPS	-	-	-	-	-2.40	-1.42
Free Cash Flow	-42.56M	-51.12M	-66.86M	-98.53M	-84.56M	-80.00M
No. Analysts	-	-	-	-	-	5

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

EPS	2026	2027	2028
High	-1.29
Avg	-1.42
Low	-1.56

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-